» Articles » PMID: 16458569

Human Neoplastic Mesothelial Cells Express Voltage-gated Sodium Channels Involved in Cell Motility

Overview
Publisher Elsevier
Date 2006 Feb 7
PMID 16458569
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Given the pivotal role of ion channels in neoplastic transformation, the aim of the present study has been to assess possible differences in the expression patterns of voltage-gated monovalent cationic (Na(+) and K(+)) currents between normal and neoplastic mesothelial cells (NM, MPM, respectively), and to evaluate the role of specific ion channels in mesothelioma cells proliferation, apoptosis, and motility. To achieve this aim, membrane currents expressed in NM and MPM cells derived from surgically-removed human specimens were investigated by means of patch-clamp electrophysiology. NM cells were found to express three main classes of K(+) currents, which were defined as K(IR), maxiK(Ca), and K(V) currents on the basis of their biophysical and pharmacological properties. Each of these K(+) currents was absent in MPM cells; by contrast, MPM cells revealed the novel appearance of tetrodotoxin (TTX)-sensitive voltage-gated Na(+) currents undetected in normal mesothelial cells. Reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time PCR analysis of MPM cells transcripts showed significant expression of the mRNAs encoding for Na(V)1.2, and Na(V)1.6, and Na(V)1.7 (and less so for Na(V)1.3, Na(V)1.4, and Na(V)1.5) main voltage-gated sodium channel (VGSC) alpha-subunit(s). Interestingly, blockade of VGSCs with TTX decreased mesothelioma cell migration in in vitro motility assays; on the other hand, TTX failed to interfere with cell viability, proliferation, and apoptosis progression triggered by UV exposure. In summary, the results of the present study suggest that VGSCs expression in MPM cells may favor the increased motility of the neoplastic cells, a phenotypic feature often associated with the malignant phenotype.

Citing Articles

A novel Na1.5-dependent feedback mechanism driving glycolytic acidification in breast cancer metastasis.

Leslie T, Tripp A, James A, Fraser S, Nelson M, Sajjaboontawee N Oncogene. 2024; 43(34):2578-2594.

PMID: 39048659 PMC: 11329375. DOI: 10.1038/s41388-024-03098-x.


Therapeutic targeting of voltage-gated sodium channel Na1.7 for cancer metastasis.

Pukkanasut P, Jaskula-Sztul R, Gomora J, Velu S Front Pharmacol. 2024; 15:1416705.

PMID: 39045054 PMC: 11263763. DOI: 10.3389/fphar.2024.1416705.


Disrupting Na ion homeostasis and Na/K ATPase activity in breast cancer cells directly modulates glycolysis in vitro and in vivo.

Michaels A, Zoccarato A, Hoare Z, Firth G, Chung Y, Kuchel P Cancer Metab. 2024; 12(1):15.

PMID: 38783368 PMC: 11119389. DOI: 10.1186/s40170-024-00343-5.


Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets.

Sanchez-Sandoval A, Hernandez-Plata E, Gomora J Front Pharmacol. 2023; 14:1206136.

PMID: 37456756 PMC: 10348687. DOI: 10.3389/fphar.2023.1206136.


Potassium and Sodium Channels and the Warburg Effect: Biophysical Regulation of Cancer Metabolism.

Iorio J, Petroni G, Duranti C, Lastraioli E Bioelectricity. 2021; 1(3):188-200.

PMID: 34471821 PMC: 8370285. DOI: 10.1089/bioe.2019.0017.